Alzheimer's disease

What are the early signs of Alzheimer’s disease? Can it be treated, and which specialist should you consult if memory problems begin to affect daily life?

Alzheimer’s disease is a progressive neurological condition that can affect memory, language, thinking, judgment and the ability to perform everyday activities.

It is the most common cause of dementia, but not every memory problem is caused by Alzheimer’s. Depression, sleep disturbances, medication effects, certain nutritional deficiencies and other medical conditions can contribute to cognitive difficulties.

When changes in memory or thinking interfere with everyday functioning, a medical evaluation can help identify the cause and guide appropriate treatment.

On Tabeebo, patients and families can explore healthcare professionals associated with Alzheimer’s care, compare available provider information and find relevant specialists.

What Are the Early Signs of Alzheimer’s Disease?

Symptoms develop differently among individuals, but Alzheimer’s generally progresses gradually.

Common warning signs include:

  • Frequently forgetting recently learned information.
  • Repeatedly asking the same questions.
  • Difficulty managing finances or following plans.
  • Becoming lost in familiar surroundings.
  • Struggling to find words or follow conversations.
  • Confusion about dates, places or familiar tasks.
  • Changes in judgment, mood or behavior.
  • Increasing difficulty completing activities that were previously manageable.

As the condition progresses, patients may need additional help with personal care, communication, mobility and daily routines.

Normal age-related forgetfulness is not the same as progressive cognitive impairment that interferes with independence.

Sudden confusion, abrupt speech difficulties or new weakness may indicate an urgent medical problem, such as stroke, and require immediate assessment.

How Is Alzheimer’s Disease Diagnosed?

An Alzheimer’s evaluation typically involves several assessments rather than one definitive test.

A neurologist, geriatrician or memory specialist may use:

Assessment Main purpose
Medical history and discussion with family Identify when symptoms began and how they affect daily life
Cognitive assessments Evaluate memory, attention, language and thinking
Laboratory tests Investigate other possible causes of cognitive difficulties
Brain MRI or other imaging Assess brain structures and alternative explanations
Alzheimer’s biomarker testing Evaluate disease-associated biological changes when clinically appropriate

Newer blood-based tests can help assess Alzheimer’s-associated amyloid pathology in selected patients with cognitive symptoms.

In May 2025, the FDA cleared the first blood test intended to assist with this diagnostic process in specified symptomatic adults.

However, blood biomarker testing is not a stand-alone diagnosis or a general screening test for everyone without symptoms.

The clinician must interpret results together with the person’s medical history, examination and other findings.

Is There a Treatment for Alzheimer’s Disease?

As of November 2026, there is no treatment that reliably cures Alzheimer’s disease or reverses it in all patients.

However, different treatments may help relieve symptoms, support everyday functioning or, in selected patients, modestly slow disease progression.

1. Medications That Help Manage Symptoms

Several medicines can provide symptomatic benefit for suitable patients.

Donepezil, rivastigmine and galantamine are cholinesterase inhibitors that may help reduce or control certain cognitive symptoms.

Memantine may be used in selected patients, particularly those with moderate to severe Alzheimer’s disease.

These medicines can support functioning or symptom management, but they do not reliably stop the underlying neurodegenerative process.

Side effects, other medications and the patient’s health must be considered when selecting and monitoring treatment.

2. Disease-Modifying Anti-Amyloid Therapies

More recent treatments include lecanemab (Leqembi) and donanemab (Kisunla), which target amyloid-beta pathology associated with Alzheimer’s disease.

These medicines have regulatory approval in the United States and European Union for particular groups of patients with early symptomatic Alzheimer’s, subject to different eligibility criteria.

Clinical trials demonstrated modest slowing of cognitive and functional decline in selected patients.

However, neither treatment is a cure, and neither is suitable for everyone with dementia.

Eligibility assessment generally involves:

  • Confirming that the patient has an appropriate early stage of Alzheimer’s disease.
  • Establishing evidence of amyloid pathology.
  • Reviewing medical history and medications.
  • Assessing the risks associated with APOE ε4 status.
  • Performing MRI examinations before and during treatment.
  • Ensuring access to a specialist team experienced with these therapies.

An important complication is amyloid-related imaging abnormalities (ARIA), which may involve brain swelling or bleeding.

Although some cases produce no symptoms, serious and potentially life-threatening events can occur.

Treatment therefore requires careful shared decision-making and ongoing monitoring.

Drug approval does not guarantee local availability. Patients should confirm whether a specific medication and the required monitoring are available and authorized in their country and at their chosen healthcare facility.

Non-Drug Treatment and Rehabilitation

Medication is only one component of Alzheimer’s management.

Depending on the person’s needs and the stage of disease, supportive care may include:

  • Appropriate physical activity.
  • Cognitive stimulation and meaningful activities.
  • Occupational therapy and rehabilitation.
  • Assessment and management of sleep problems.
  • Treatment of depression or anxiety when present.
  • Structured routines and environmental adjustments.
  • Hearing and vision support.
  • Nutritional assistance when needed.
  • Education and support for family caregivers.

These measures do not cure Alzheimer’s but can help maintain daily functioning, comfort, safety and quality of life.

The appropriate combination should reflect the person’s abilities, symptoms and preferences.

What Does Alzheimer’s Care at Home Involve?

As the disease progresses, families may need to provide more assistance with medication management, appointments, meals, personal care and safe mobility.

A predictable daily routine, clear reminders, reduced fall hazards and accessible emergency information may be helpful.

It is also important to discuss driving, financial arrangements and future care preferences while the person can participate meaningfully in decisions.

Caregiver support should not be overlooked. Family members may benefit from education, respite services, counseling and community resources.

Good dementia care should preserve the person’s dignity, preferences and independence as much as possible.

When Should Someone See an Alzheimer’s Specialist?

Consider a medical appointment when memory or thinking difficulties repeatedly affect familiar activities, finances, medication management, communication or navigation.

Seeking an assessment can help identify potentially treatable contributors to cognitive symptoms and establish an appropriate care plan.

Some people may be referred to a neurologist, geriatrician or specialized memory clinic for further evaluation.

Sudden confusion or acute neurological changes require urgent evaluation, not a routine Alzheimer’s appointment.

How to Find the Right Alzheimer’s Specialist

A healthcare professional experienced in Alzheimer’s and other memory disorders can help coordinate diagnosis, treatment and follow-up.

When comparing specialists, consider:

  • Recognized qualifications and professional registration.
  • Experience evaluating Alzheimer’s and other causes of cognitive impairment.
  • Availability of appropriate cognitive assessment and diagnostic testing.
  • Ability to provide continuing care and medication review.
  • Coordination with rehabilitation and caregiver-support services.
  • Access to relevant specialist monitoring if newer treatments are being considered.

You can explore neurologists listed on Tabeebo and review the provider profiles associated with this Alzheimer’s treatment page.

A specialist’s presence in the directory does not mean that they offer anti-amyloid infusions, blood biomarker testing or every advanced treatment. Confirm those services with the provider directly.

Frequently Asked Questions

Is Alzheimer’s the Same as Normal Age-Related Forgetfulness?

No. Occasional forgetfulness can occur with aging, while Alzheimer’s typically involves progressive changes that increasingly interfere with daily activities.

Can Alzheimer’s Be Cured?

There is currently no cure. Treatment may relieve symptoms and, in selected early-stage patients, slow aspects of disease progression.

What Is the Best Medication for Alzheimer’s?

There is no single best medication for everyone. The choice depends on disease stage, medical history, treatment goals, possible adverse effects and local availability.

Can a Blood Test Diagnose Alzheimer’s?

Blood-based biomarkers may assist diagnosis in appropriate symptomatic patients, but results must be interpreted alongside other clinical information.

Can Exercise or Diet Replace Alzheimer’s Medication?

No. Healthy lifestyle habits can support overall health and may help reduce certain dementia risks, but they do not replace appropriate medical care.

Which Doctor Treats Alzheimer’s Disease?

Neurologists, geriatricians and specialists working in memory clinics may diagnose and manage Alzheimer’s, often alongside other healthcare professionals.

Conclusion: Individualized Treatment and Long-Term Support Matter

Although Alzheimer’s remains a progressive disease without a cure, early evaluation and coordinated care can make a meaningful difference.

Current treatment options include symptomatic medications, selected disease-modifying therapies and a wide range of rehabilitation and caregiver-support services.

The right approach depends on an accurate diagnosis, the person’s stage of disease, overall health and individual priorities.

To learn more about recent scientific developments, read Tabeebo’s latest Alzheimer’s research guide.

Tabeebo is a healthcare directory, not a direct medical provider. It helps patients and families explore healthcare services and compare professionals before arranging an individualized consultation.


Medical References

  1. WHO — Dementia, July 2026
  2. National Institute on Aging — How Is Alzheimer’s Disease Treated?
  3. FDA — First Blood Test Used in Diagnosing Alzheimer’s Disease
  4. European Medicines Agency — Leqembi (Lecanemab)
  5. European Medicines Agency — Kisunla (Donanemab)
  6. WHO — Risk Reduction of Cognitive Decline and Dementia, 2026

Medical disclaimer: This information is educational and does not replace medical diagnosis, prescribing decisions or treatment monitoring by a qualified healthcare professional.

Do you need to talk? Let us help you.

That's why our support team is here — to listen, guide, and help you with whatever you need.

Contact Us